Who won ASCO? Is pharma sandbagging its blockbusters? And what do gladiators have to do with biotech?
We discuss all that and more on the latest episode of “The Readout LOUD,” STAT’s biotech podcast. First, STAT’s Matthew Herper joins us to break down the busts and breakthroughs at the biggest annual oncology conference. Then we discuss a Washington Post story, about the reportedly ignored promise of a Pfizer drug, that riled up virtually all of biotech. Finally, STAT’s Kate Sheridan dials in from Philadelphia to dish on the annual BIO conference and an adjacent — and infamous — party.
For more on what we cover, here’s an ASCO recap; here’s the Post story; and here’s the scoop on that BIO party.
We’ll be back next Thursday evening — and every Thursday evening — so be sure to sign up on iTunes, Stitcher, Google Play, or wherever you get your podcasts.
And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].
Interested in sponsoring a future episode of “The Readout LOUD”? Email us at [email protected].